One million haemopoietic stem-cell transplants: a retrospective observational study (Q38384271)

2 September 2017

One million haemopoietic stem-cell transplants: a retrospective observational study (English)

1 reference

2 September 2017

12

Hildegard Greinix

1 reference

2 September 2017

1

Alois Gratwohl

1 reference

2 September 2017

11

Eliane Gluckman

1 reference

2 September 2017

28

Dietger Niederwieser

1 reference

2 September 2017

Marcelo C Pasquini

2

1 reference

2 September 2017

Mahmoud Aljurf

3

1 reference

2 September 2017

Yoshiko Atsuta

4

1 reference

2 September 2017

Helen Baldomero

5

1 reference

2 September 2017

Lydia Foeken

6

1 reference

2 September 2017

Michael Gratwohl

7

1 reference

2 September 2017

Luis Fernando Bouzas

8

1 reference

2 September 2017

Dennis Confer

9

1 reference

2 September 2017

Karl Frauendorfer

10

1 reference

2 September 2017

Mary Horowitz

13

1 reference

2 September 2017

Minako Iida

14

1 reference

2 September 2017

Jeff Lipton

15

1 reference

2 September 2017

Alejandro Madrigal

16

1 reference

2 September 2017

Mohamad Mohty

17

1 reference

2 September 2017

Luc Noel

18

1 reference

2 September 2017

Nicolas Novitzky

19

1 reference

2 September 2017

José Nunez

20

1 reference

2 September 2017

Machteld Oudshoorn

21

1 reference

2 September 2017

Jakob Passweg

22

1 reference

2 September 2017

Jon van Rood

23

1 reference

2 September 2017

Jeff Szer

24

1 reference

2 September 2017

Karl Blume

25

1 reference

2 September 2017

Frederic R Appelbaum

26

1 reference

2 September 2017

Yoshihisa Kodera

27

1 reference

2 September 2017

Worldwide Network for Blood and Marrow Transplantation (WBMT)

29

1 reference

2 September 2017

27 February 2015

1 reference

2 September 2017

The Lancet. Haematology.

1 reference

2 September 2017

2

1 reference

2 September 2017

e91-100

1 reference

2 September 2017

3

1 reference

Globally consistent coding systems for medical products of human origin

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

History of solid organ transplantation and organ donation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Regulating stem-cell therapies worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

The politics of combating the organ trade: lessons from the Israeli and Pakistani experience

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

WHO guiding principles on human cell, tissue and organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Best practices in regulation of blood and blood products

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Coverage options for promising technologies: Medicare's 'coverage with evidence development'

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

A New Dawn for Stem-Cell Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Cardiac tissue engineering: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Engineered autologous cartilage tissue for nasal reconstruction after tumour resection: an observational first-in-human trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

A compendium of reported human bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

The EBMT activity survey: 1990-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Hematopoietic stem cell transplantation: a global perspective

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Autologous bone marrow transplantation. Current status and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Marrow Transplantation for Nonmalignant Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Reduced mortality after allogeneic hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

US company comes under fire over patent on umbilical cord cells.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

1 reference

7 January 2021

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

Stricter management of organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS2352-3026%2815%2900028-9

7 January 2021

10.1016/S2352-3026(15)00028-9

Identifiers

DOI

1 reference

2 September 2017

1 reference